Advertisement

How AbbVie Could Make an Entry Into This Rapidly Growing Drug Market

How AbbVie Could Make an Entry Into This Rapidly Growing Drug Market

Venclexta's potential indication for the treatment of myelodysplastic syndrome could mean billions for AbbVie this decade.